Johnson & Johnson Innovation-JJDC Inc.
07/23/2026 | Press release | Distributed by Public on 07/23/2026 08:00
Johnson & Johnson names awardees in second cohort of the Polyphonic™ AI Fund for Surgery QuickFire Challenge
July 23, 2026 - Today at the 2026 Society of Robotic Surgery (SRS) Annual Meeting, Johnson & Johnson announced that C1DO1, Curium Life Tech, and iQ Surgical have been selected as the second cohort awardees of the Polyphonic™ AI Fund for Surgery QuickFire Challenge.
For this global initiative, researchers and innovators in the Surgical Data Science field were invited to submit their ideas for artificial intelligence (AI) technologies that have the potential to improve surgical decision-making, strengthen data management and governance processes, and drive surgical efficiency across the connected operating room.
The awardees of this second cohort are being recognized for their potentially groundbreaking AI technologies aimed at enhancing surgical care and improving patient outcomes.
C1DO1: C1DO1 is an AI-enabled competency-based learning platform that enables learners to upload videos of practical skill performance and support asynchronous multimedia feedback, assessment, and coaching.
Curium Life Tech: Curium Life Tech is a deep tech surgical AI startup company founded and led by surgeons, with a mission to advance intelligent, data-driven decision support inside the operating room. The company is working to develop geometry-aware surgical foundation models designed specifically for abdominal and soft tissue surgeries, for use by surgeons, hospitals, laparoscopic system manufacturers, and robotic surgery companies developing surgical AI applications.
iQ Surgical: iQ Surgical is developing AI co-surgeons technologies for surgical decision-making in real time.
The awardees will receive award funding and mentorship from experts across Johnson & Johnson.* Awardees may also be eligible to receive computing tools and technologies to help advance their innovations.
*Subject to terms and conditions of applicable QuickFire Challenge and execution of an award agreement
About Johnson & Johnson
Johnson & Johnson works across the innovative medicine and medical technology sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and startup services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists, and emerging companies. Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health. Meet our passionate team of science and technology experts and learn how to collaborate with us at www.jnjinnovation.com.
Johnson & Johnson Innovation-JJDC Inc. published this content on July 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 23, 2026 at 14:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]